
QURE
Healthcare · Biotechnology · $1.67B market cap
$23.81-0.82 (-3.3%)Nov 13, 4:00 PM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · +8.9% over 90 days · 30-day revisions 2 up, 2 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 4, 2026 | Before the open | -0.84 | -0.88 | -4.8% |
| Jul 29, 2026 | Before the open | -0.81 | -1.22 | -50.6% |
| May 5, 2026 | Before the open | -0.75 | -0.73 | +2.7% |
| Mar 2, 2026 | Time not confirmed | -0.92 | -0.47 | +48.3% |
| Nov 10, 2025 | Before the open | -0.75 | -1.19 | -58.7% |
| Jul 29, 2025 | Before the open | -0.76 | -0.60 | +21.1% |
| May 9, 2025 | Before the open | -0.93 | -0.73 | +21.5% |
| Feb 24, 2025 | Before the open | -0.52 | -1.44 | -178.8% |
| Nov 5, 2024 | Before the open | -0.93 | -0.84 | +9.7% |
| Aug 1, 2024 | Before the open | -1.16 | -1.08 | +6.9% |
| May 7, 2024 | Before the open | -1.16 | -1.26 | -8.6% |
| Feb 28, 2024 | Before the open | -1.46 | -1.53 | -4.8% |
| Nov 7, 2023 | Before the open | -0.72 |
uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of bleeding. Its lead product candidate is AMT-130, a gene therapy candidate, which is in Phase I/II clinical study for the treatment of Huntington's disease. The company also…
| -1.75 |
| -143.1% |
| Aug 1, 2023 | Before the open | 2.81 | -1.31 | -146.6% |
| May 9, 2023 | Before the open | -0.87 | -1.48 | -70.1% |
| Feb 27, 2023 | Before the open | -0.89 | 0.15 | +116.9% |
| Nov 2, 2022 | Before the open | -1.11 | -1.03 | +7.2% |
| Aug 8, 2022 | Before the open | -0.91 | -0.83 | +8.8% |
| May 2, 2022 | Before the open | -0.79 | -0.95 | -20.3% |
| Feb 25, 2022 | Before the open | -0.81 | 0.17 | +121.0% |
| Oct 25, 2021 | Before the open | -0.91 | -0.68 | +25.3% |
| Jul 26, 2021 | Before the open | 2.18 | 7.23 | +231.7% |
| May 10, 2021 | Before the open | -0.77 | -0.75 | +2.6% |
| Mar 1, 2021 | Before the open | 1.52 | -0.01 | -100.7% |
| Oct 27, 2020 | Before the open | -0.76 | -1.02 | -34.2% |
| Jul 30, 2020 | Before the open | -0.52 | -0.82 | -57.7% |
| Apr 29, 2020 | Before the open | -0.73 | -0.58 | +20.5% |
| Mar 2, 2020 | After the close | -0.73 | -0.96 | -31.5% |
| Oct 28, 2019 | Before the open | -0.74 | -0.52 | +29.7% |
| Jul 29, 2019 | Before the open | -0.67 | -0.75 | -11.9% |
| Apr 29, 2019 | Before the open | -0.63 | -0.66 | -4.8% |
| Feb 28, 2019 | Before the open | -0.66 | -0.59 | +10.6% |
| Nov 6, 2018 | Before the open | -0.54 | -0.52 | +3.7% |
| Aug 8, 2018 | Before the open | -0.52 | -0.49 | +5.8% |
| Apr 30, 2018 | Before the open | -0.61 | -0.49 | +19.7% |
| Mar 14, 2018 | Before the open | -0.77 | -0.91 | -18.2% |